These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32400862)

  • 21. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
    Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
    J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of
    Li Q; Zhan X; Tan Y
    Discov Med; 2024 Jun; 36(185):1280-1288. PubMed ID: 38926114
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Huang C; Wang L; Song H; Wu C
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3037-3042. PubMed ID: 31342798
    [No Abstract]   [Full Text] [Related]  

  • 24. [Preliminary study on the role of voltage-gated sodium channel subtype Nav1.5 in lymph node metastasis of oral squamous cell carcinoma].
    Liu WJ; Xu L; Zhu XW; Chen XF; Wang H; Jiang Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Mar; 52(3):188-193. PubMed ID: 28279058
    [No Abstract]   [Full Text] [Related]  

  • 25. Long non-coding RNA UCA1 contributes to the progression of oral squamous cell carcinoma by regulating the WNT/β-catenin signaling pathway.
    Yang YT; Wang YF; Lai JY; Shen SY; Wang F; Kong J; Zhang W; Yang HY
    Cancer Sci; 2016 Nov; 107(11):1581-1589. PubMed ID: 27560546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway.
    Yu T; Liu K; Wu Y; Fan J; Chen J; Li C; Yang Q; Wang Z
    Oncogene; 2014 Oct; 33(42):5017-27. PubMed ID: 24141785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KLK4 silencing inhibits the growth of oral squamous cell carcinoma through Wnt/β-catenin signaling pathway.
    Cui Z; Cui Y; Yang S; Luo G; Wang Y; Lou Y; Sun X
    Cell Biol Int; 2017 Apr; 41(4):392-404. PubMed ID: 28150891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA‑199a‑5p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMT‑related transcription factor SOX4.
    Wei D; Wang W; Shen B; Zhou Y; Yang X; Lu G; Yang J; Shao Y
    Int J Mol Med; 2019 Jul; 44(1):185-195. PubMed ID: 31059001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic restraint stress promotes the tumorigenic potential of oral squamous cell carcinoma cells by reprogramming fatty acid metabolism via CXCL3 mediated Wnt/β-catenin pathway.
    Lou F; Long H; Luo S; Liu Y; Pu J; Wang H; Ji P; Jin X
    Exp Neurol; 2023 Jan; 359():114268. PubMed ID: 36343679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of IFI27 inhibits cell proliferation and invasion in oral squamous cell carcinoma.
    Wang H; Qiu X; Lin S; Chen X; Wang T; Liao T
    World J Surg Oncol; 2018 Mar; 16(1):64. PubMed ID: 29580248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific knockdown of HOXB7 inhibits cutaneous squamous cell carcinoma cell migration and invasion while inducing apoptosis via the Wnt/β-catenin signaling pathway.
    Gao D; Chen HQ
    Am J Physiol Cell Physiol; 2018 Nov; 315(5):C675-C686. PubMed ID: 30067384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
    Prgomet Z; Axelsson L; Lindberg P; Andersson T
    J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tspan15 plays a crucial role in metastasis in oral squamous cell carcinoma.
    Hiroshima K; Shiiba M; Oka N; Hayashi F; Ishida S; Fukushima R; Koike K; Iyoda M; Nakashima D; Tanzawa H; Uzawa K
    Exp Cell Res; 2019 Nov; 384(2):111622. PubMed ID: 31518558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MFAP2 promotes the progression of oral squamous cell carcinoma by activating the Wnt/β-catenin signaling pathway through autophagy.
    Zhang H; Shen S; Feng C; Chen G; Wang X
    Acta Biochim Biophys Sin (Shanghai); 2023 Aug; 55(9):1445-1455. PubMed ID: 37592847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Casticin inhibits invasion and proliferation via downregulation of β-catenin and reversion of EMT in oral squamous cell carcinoma.
    Xie Y; Zhong L; Duan D; Li T
    J Oral Pathol Med; 2019 Nov; 48(10):897-905. PubMed ID: 31318467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway.
    Huang G; Chen S; Washio J; Paka Lubamba G; Takahashi N; Li C
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wnt/β-catenin signaling pathway participates in the effect of miR-626 on oral squamous cell carcinoma by targeting RASSF4.
    Cui SH; Hu XD; Yan Y
    J Oral Pathol Med; 2021 Nov; 50(10):1005-1017. PubMed ID: 34121238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells.
    Wang SH; Chang JS; Hsiao JR; Yen YC; Jiang SS; Liu SH; Chen YL; Shen YY; Chang JY; Chen YW
    Oncogene; 2017 Mar; 36(11):1503-1515. PubMed ID: 27593938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of Dkk-3 decreases cancer cell migration and invasion independently of the Wnt pathways in oral squamous cell carcinoma‑derived cells.
    Katase N; Lefeuvre M; Tsujigiwa H; Fujii M; Ito S; Tamamura R; Buery RR; Gunduz M; Nagatsuka H
    Oncol Rep; 2013 Apr; 29(4):1349-55. PubMed ID: 23354949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.